Cargando…
Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes
The risk determinants of type 1 diabetes, initiators of autoimmune response, mechanisms regulating progress toward β cell failure, and factors determining time of presentation of clinical diabetes are poorly understood. We investigated changes in the serum metabolome prospectively in children who la...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605239/ https://www.ncbi.nlm.nih.gov/pubmed/19075291 http://dx.doi.org/10.1084/jem.20081800 |
_version_ | 1782162829960282112 |
---|---|
author | Orešič, Matej Simell, Satu Sysi-Aho, Marko Näntö-Salonen, Kirsti Seppänen-Laakso, Tuulikki Parikka, Vilhelmiina Katajamaa, Mikko Hekkala, Anne Mattila, Ismo Keskinen, Päivi Yetukuri, Laxman Reinikainen, Arja Lähde, Jyrki Suortti, Tapani Hakalax, Jari Simell, Tuula Hyöty, Heikki Veijola, Riitta Ilonen, Jorma Lahesmaa, Riitta Knip, Mikael Simell, Olli |
author_facet | Orešič, Matej Simell, Satu Sysi-Aho, Marko Näntö-Salonen, Kirsti Seppänen-Laakso, Tuulikki Parikka, Vilhelmiina Katajamaa, Mikko Hekkala, Anne Mattila, Ismo Keskinen, Päivi Yetukuri, Laxman Reinikainen, Arja Lähde, Jyrki Suortti, Tapani Hakalax, Jari Simell, Tuula Hyöty, Heikki Veijola, Riitta Ilonen, Jorma Lahesmaa, Riitta Knip, Mikael Simell, Olli |
author_sort | Orešič, Matej |
collection | PubMed |
description | The risk determinants of type 1 diabetes, initiators of autoimmune response, mechanisms regulating progress toward β cell failure, and factors determining time of presentation of clinical diabetes are poorly understood. We investigated changes in the serum metabolome prospectively in children who later progressed to type 1 diabetes. Serum metabolite profiles were compared between sample series drawn from 56 children who progressed to type 1 diabetes and 73 controls who remained nondiabetic and permanently autoantibody negative. Individuals who developed diabetes had reduced serum levels of succinic acid and phosphatidylcholine (PC) at birth, reduced levels of triglycerides and antioxidant ether phospholipids throughout the follow up, and increased levels of proinflammatory lysoPCs several months before seroconversion to autoantibody positivity. The lipid changes were not attributable to HLA-associated genetic risk. The appearance of insulin and glutamic acid decarboxylase autoantibodies was preceded by diminished ketoleucine and elevated glutamic acid. The metabolic profile was partially normalized after the seroconversion. Autoimmunity may thus be a relatively late response to the early metabolic disturbances. Recognition of these preautoimmune alterations may aid in studies of disease pathogenesis and may open a time window for novel type 1 diabetes prevention strategies. |
format | Text |
id | pubmed-2605239 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-26052392009-06-22 Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes Orešič, Matej Simell, Satu Sysi-Aho, Marko Näntö-Salonen, Kirsti Seppänen-Laakso, Tuulikki Parikka, Vilhelmiina Katajamaa, Mikko Hekkala, Anne Mattila, Ismo Keskinen, Päivi Yetukuri, Laxman Reinikainen, Arja Lähde, Jyrki Suortti, Tapani Hakalax, Jari Simell, Tuula Hyöty, Heikki Veijola, Riitta Ilonen, Jorma Lahesmaa, Riitta Knip, Mikael Simell, Olli J Exp Med Articles The risk determinants of type 1 diabetes, initiators of autoimmune response, mechanisms regulating progress toward β cell failure, and factors determining time of presentation of clinical diabetes are poorly understood. We investigated changes in the serum metabolome prospectively in children who later progressed to type 1 diabetes. Serum metabolite profiles were compared between sample series drawn from 56 children who progressed to type 1 diabetes and 73 controls who remained nondiabetic and permanently autoantibody negative. Individuals who developed diabetes had reduced serum levels of succinic acid and phosphatidylcholine (PC) at birth, reduced levels of triglycerides and antioxidant ether phospholipids throughout the follow up, and increased levels of proinflammatory lysoPCs several months before seroconversion to autoantibody positivity. The lipid changes were not attributable to HLA-associated genetic risk. The appearance of insulin and glutamic acid decarboxylase autoantibodies was preceded by diminished ketoleucine and elevated glutamic acid. The metabolic profile was partially normalized after the seroconversion. Autoimmunity may thus be a relatively late response to the early metabolic disturbances. Recognition of these preautoimmune alterations may aid in studies of disease pathogenesis and may open a time window for novel type 1 diabetes prevention strategies. The Rockefeller University Press 2008-12-22 /pmc/articles/PMC2605239/ /pubmed/19075291 http://dx.doi.org/10.1084/jem.20081800 Text en © 2008 Orešič et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/). |
spellingShingle | Articles Orešič, Matej Simell, Satu Sysi-Aho, Marko Näntö-Salonen, Kirsti Seppänen-Laakso, Tuulikki Parikka, Vilhelmiina Katajamaa, Mikko Hekkala, Anne Mattila, Ismo Keskinen, Päivi Yetukuri, Laxman Reinikainen, Arja Lähde, Jyrki Suortti, Tapani Hakalax, Jari Simell, Tuula Hyöty, Heikki Veijola, Riitta Ilonen, Jorma Lahesmaa, Riitta Knip, Mikael Simell, Olli Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes |
title | Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes |
title_full | Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes |
title_fullStr | Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes |
title_full_unstemmed | Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes |
title_short | Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes |
title_sort | dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605239/ https://www.ncbi.nlm.nih.gov/pubmed/19075291 http://dx.doi.org/10.1084/jem.20081800 |
work_keys_str_mv | AT oresicmatej dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes AT simellsatu dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes AT sysiahomarko dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes AT nantosalonenkirsti dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes AT seppanenlaaksotuulikki dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes AT parikkavilhelmiina dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes AT katajamaamikko dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes AT hekkalaanne dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes AT mattilaismo dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes AT keskinenpaivi dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes AT yetukurilaxman dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes AT reinikainenarja dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes AT lahdejyrki dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes AT suorttitapani dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes AT hakalaxjari dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes AT simelltuula dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes AT hyotyheikki dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes AT veijolariitta dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes AT ilonenjorma dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes AT lahesmaariitta dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes AT knipmikael dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes AT simellolli dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes |